Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...
Phase 2b PLATEAU clinical trial evaluating enobosarm in combination with semaglutide in older patients with obesity on track to initiate this quarter— --Company to host conference call and webcast ...
Less than 10% of dreaded outcomes ever tend to occur. Here, four doctors of psychiatry and psychology offer strategies to ...